Termination Reimbursement scheme Forxiga®/Xigduo® - Diabetes
As from the 1st of August 2025 the “bijlage 2 voorwaarden” for Forxiga® and Xigduo® have been withdrawn. This means that per 1st...
Termination Reimbursement scheme Cresemba® 40 mg en 100mg
From August 1st 2025 onwards, Cresemba® 40 mg en 100mg is fully reimbursed by the health insurer. Therefore the...
Update Reimbursement Scheme Cresemba®
The health insurer does not fully reimburse Cresemba® 40 mg and 100 mg. The producer of this medicine has therefore asked TBR...
Update Reimbursement Scheme Metoject®
From January 1, 2025 the use of Metoject Pen® 7.5mg will be fully reimbursed by the Health Insurer. For this reason the...
Reimbursement Scheme Mounjaro KwikPen® for the indication Diabetes Mellitus type 2
The health insurer does not fully reimburse Mounjaro KwikPen for the indication Diabetes Mellitus type 2. The producer of this...
Select your medicine
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine